KRT18 and metabolic dysfunction-associated steatohepatitis: CK-18 was an independent predictor of both NASH and severity of disease.130 Other studies have corroborated these findings,131–137 suggesting that CK-18 represents a potentially useful biomarker for the diagnosis and differentiation of NASH from simple steatosis.